Know Cancer

or
forgot password

Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls


N/A
19 Years
75 Years
Open (Enrolling)
Female
Thyroid Cancer, Papillary, Leptin Levels

Thank you

Trial Information

Assessment of Serum Leptin Levels in Females With Papillary Thyroid Carcinoma, Benign Thyroid Nodules, and Normal Controls


There will be three groups in this study, but 2 of the groups are part of another study so
will only recruit normal controls.


Inclusion Criteria:



- Female

- Age>/- 19

- Not currently pregnant or lactating

- Normal thyroid gland by history

Exclusion Criteria:

- Male Gender

- Pregnancy

- Lactation

- Age below 19

- Abnormal thyroid gland by history

- Abnormal thyroid gland by structure using ultrasound

- Abnormal thyroid gland by function using TSH, Free T4

Type of Study:

Observational

Study Design:

Time Perspective: Cross-Sectional

Outcome Measure:

evaluating Leptin level Evaluating Serum Leptin Levels Between 3 Groups. One Group with Papillary Thyroid Carcinoma. One Group With Benign Nodules. One Group with Normal Thyroid.

Outcome Description:

Assessing serum leptin levels in females with treated papillary thyroid carcinoma and compared to females with proven benign thyroid nodules and females with normal thyroid glands. All groups were matched by gender, age, and BMI to limit confounders.

Outcome Time Frame:

During Study

Safety Issue:

No

Principal Investigator

Whitney Goldner, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

University of Nebraska

Authority:

United States: Institutional Review Board

Study ID:

276-12-EP

NCT ID:

NCT01659385

Start Date:

August 2012

Completion Date:

June 2013

Related Keywords:

  • Thyroid Cancer, Papillary
  • Leptin Levels
  • Thyroid Neoplasms
  • Thyroid Diseases

Name

Location

University of Nebraska Medical CenterOmaha, Nebraska  68198-3330